Related Experiment Videos

Prevention of obesity in Avy/a mice by dehydroepiandrosterone

Lipids
|May 1, 1977
PubMed

Insights

Dehydroepiandrosterone (DHEA) prevented obesity in Avy/a mice by reducing fat accumulation. This weight management effect was reversible and showed no appetite suppression or toxicity.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Obesity Studies

Background:

  • Obesity is a complex metabolic disorder with significant health implications.
  • Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone with potential metabolic regulatory functions.
  • Avy/a mice are a genetic model susceptible to obesity.

Purpose of the Study:

  • To investigate the effect of Dehydroepiandrosterone (DHEA) on preventing obesity in a genetic mouse model.
  • To determine the mechanisms underlying DHEA's potential weight-controlling effects.

Main Methods:

  • Administration of Dehydroepiandrosterone (DHEA) to Avy/a mice.
  • Measurement of body weight and triacylglycerol accumulation.
  • Assessment of hepatic lipogenesis using 3H2O incorporation.
  • Monitoring of appetite and potential toxic effects.

Main Results:

  • Dehydroepiandrosterone (DHEA) treatment prevented obesity in Avy/a mice.
  • Reduced triacylglycerol accumulation was a primary factor in weight difference.
  • Hepatic lipogenesis was significantly decreased in DHEA-treated mice.
  • DHEA did not suppress appetite and exhibited no apparent toxicity at tested doses.

Conclusions:

  • Dehydroepiandrosterone (DHEA) effectively prevents diet-induced obesity in Avy/a mice.
  • DHEA's anti-obesity effects are mediated, in part, by reduced hepatic lipogenesis and triacylglycerol accumulation.
  • The weight management effects of DHEA are reversible and well-tolerated.

Related Concept Videos